Company: MBVI
Filing Date: 2025-08-04
Form Type: S-1
Source: 0001213900-25-071471
Chunk: 11

Company: M3-Brigade Acquisition VI Corp.
Filing Date: 2025-08-04
Form: S-1
Chunk 11
---
 and accordingly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. The low price that our sponsor, paid for the founder shares creates an incentive whereby members of our management team and our directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. Our initial shareholders will purchase private placements warrants in a transaction that will close simultaneously with the closing of this offering. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Additionally, each of our officers and directors presently has, and any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one or more other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entities. None of our officers or directors shall have a duty to present any potential business combination opportunity to the Company. As a result, there may be actual or potential material conflicts of interest between our sponsor and its affiliates, including M3 Partners and Brigade, on one hand, and purchasers in this offering on the other. Our sponsor and our officers and directors may sponsor or form other special purpose acquisition companies similar to ours or may pursue other business or investment ventures during the period in which we are seeking an initial business combination. Furthermore, if we are unable to complete our initial business combination within the completion window (as defined herein), the founder shares and private placement warrants may expire worthless, except to the extent they receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. Further, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. See “ Summary — Sponsor Information”, “ Summary — The Offering — Conflicts of Interest”, “ Proposed Business — Sourcing of Potential Business Combination Targets” and “ Management — Conflicts of Interest” for more information. The underwriters are offering the units for sale on a firm commitment basis. The underwriters expect to deliver the units to the purchasers on or about, 2025. ___________________________________ Sole Book-Running Manager